Maintenance Notice: You may encounter a brief disruption lasting 1-2 minutes at any time between 11:00 PM GMT on 21 July 2026 and 4:00 AM GMT on 22 July 2026.

This Plain Language Summary of Publication article (PLSP) from Postgraduate Medicine examines MASLD (metabolic dysfunction-associated steatotic liver disease), a common condition characterized by excess lipid accumulation in liver cells and represents the leading cause of chronic liver disease globally. Currently, no medications are specifically approved for MASLD treatment. Management focuses on lifestyle modifications, including healthy eating, increased physical activity, and weight reduction, which can help decrease liver lipid accumulation.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis’ and was published in Clinical Gastroenterology and Hepatology.

Visit AGA using the link to read the original article.